Metigalen Lotion

Methylprednisolone aceponate, the active ingredient in Metigalen Lotion, is a corticosteroid presented as a topical lotion for skin use. It treats inflammatory skin conditions such as eczema, atopic dermatitis, psoriasis and allergic reactions in patients requiring anti‑inflammatory therapy.

GNH USA supplies Metigalen Lotion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metigalen Lotion, a topical corticosteroid, is used to manage inflammatory skin disorders.

- Eczema: reduces redness, itching and swelling associated with the condition. - Atopic dermatitis: alleviates chronic inflammation and improves skin barrier function. - Psoriasis: diminishes plaque formation and scaling. - Allergic skin reactions: suppresses acute allergic inflammation and pruritus.

Topical application of Metigalen Lotion may be associated with local and systemic adverse reactions.

Common Side Effects: - Skin irritation or burning sensation. - Pruritus or mild itching. - Dryness or flaking of the treated area. - Folliculitis or acneiform eruptions. - Erythema or mild redness. - Contact dermatitis.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Telangiectasia (visible small blood vessels). - Secondary bacterial, fungal or viral infection. - Systemic adrenal suppression. - Cushing's syndrome with prolonged use. - Severe hypersensitivity reactions such as angioedema.

When using Metigalen Lotion, consider the following safety measures.

- Apply only to intact skin: avoid broken or infected areas. - Limit duration of use: follow prescriber guidance to reduce risk of skin atrophy. - Avoid use on large body surface areas: may increase systemic absorption. - Do not use under occlusive dressings unless directed: can enhance potency. - Pregnancy and lactation: discuss risks with a healthcare provider. - Store at room temperature: keep in the original container, protect from light and moisture.

Metigalen Lotion may interact with other medications; monitor accordingly.

Major Interactions (Avoid): - Systemic glucocorticoids: concurrent use may increase risk of systemic corticosteroid side effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic exposure of the steroid. - Live vaccines: systemic absorption could reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Topical antifungal agents (azoles): may affect skin barrier and alter absorption. - Topical NSAIDs applied to the same area: may increase local irritation. - Phototherapy: combined use may enhance skin thinning and sensitivity.